|
|
 |
|
Viewing report
|
|
|
|
Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2006, Pages: 387
This report analyzes the worldwide markets for Colorectal Cancer Therapeutics in US$ Million. The major product segments analyzed are Cytotoxic Therapies (5-FU (Fluorouracil), Camptosar (Irinotecan), Eloxatin (Oxaliplatin), and Xeloda (Capecitabine), Targeted Therapies (Avastin (bevacizumab), and Erbitux (cetuximab). The report provides separate comprehensive analytics for the United States and Rest of World. Annual forecasts are provided for the period of 2001 through 2010. The report profiles 69 companies including many key and niche players worldwide such as Amgen Inc., Bristol-Myers Squibb, F.Hoffmann-La Roche Ltd., Genentech, Inc., Imclone Systems Inc., Novartis AG, Oxford Biomedica, Pfizer Inc., Sanofi-Aventis, and Schering AG. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
Customers who bought this item also bought
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
The Cancer Clock
Cancer Colorectal Cancer or Colon Cancer
Innovations in Cancer: Novel Therapeutics, New Diagnostics and Future R&D Strategies
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
New Concepts in Cancer Therapeutics
Current and Future Therapies for Colorectal Cancer - A Therapeutic & Competitive Insight
Anticancer Therapeutics
U.S., European, and Japanese Cancer Therapeutics Markets
New Cancer Therapeutics: An Analysis Of Current And Emerging Markets
Cancer Therapeutics 2006: Market Dynamics and R&D Trends
The French Cancer Diagnostics Market
|
|
|
|
